Neogen (NASDAQ:NEOG) Cut to Buy at Wall Street Zen

Posted by Geri Gentry on Sep 23rd, 2026

Wall Street Zen lowered shares of Neogen (NASDAQ:NEOG – Free Report) from a strong-buy rating to a buy rating in a research report report published on Sunday morning,Wall Street Zen reports.

NEOG has been the topic of several other reports. Weiss Ratings upgraded Neogen from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, August 7th. Piper Sandler upgraded Neogen from a “neutral” rating to an “overweight” rating and boosted their price objective for the company from $13.00 to $14.00 in a research report on Wednesday, August 26th. Three investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $12.00.

Get Our Latest Analysis on Neogen

Neogen Trading Up 2.7%

NEOG opened at $13.98 on Friday. The company has a debt-to-equity ratio of 0.38, a current ratio of 3.82 and a quick ratio of 2.91. The company has a market cap of $3.05 billion, a price-to-earnings ratio of -466.00, a price-to-earnings-growth ratio of 5.10 and a beta of 1.76. The firm has a 50 day simple moving average of $11.44 and a 200 day simple moving average of $10.00. Neogen has a fifty-two week low of $5.09 and a fifty-two week high of $14.18.

Neogen (NASDAQ:NEOG – Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The company reported $0.09 earnings per share for the quarter, beating the consensus estimate of $0.06 by $0.03. Neogen had a negative net margin of 0.91% and a positive return on equity of 2.78%. The business had revenue of $225.30 million for the quarter, compared to analyst estimates of $212.35 million. During the same period in the prior year, the business posted ($2.82) earnings per share. Neogen’s revenue was down .1% compared to the same quarter last year. On average, sell-side analysts anticipate that Neogen will post 0.27 earnings per share for the current year.

Institutional Trading of Neogen

Institutional investors have recently modified their holdings of the business. Sequoia Financial Advisors LLC bought a new position in shares of Neogen in the 2nd quarter worth about $94,000. Integrated Wealth Concepts LLC bought a new stake in shares of Neogen during the 2nd quarter valued at about $73,000. Squarepoint Ops LLC bought a new stake in shares of Neogen during the 2nd quarter valued at about $2,642,000. Nykredit A S acquired a new stake in Neogen during the second quarter worth approximately $28,000. Finally, Corient Private Wealth LP grew its stake in Neogen by 9.1% during the second quarter. Corient Private Wealth LP now owns 46,474 shares of the company’s stock worth $418,000 after purchasing an additional 3,859 shares during the period. Institutional investors own 96.73% of the company’s stock.

Neogen News Roundup

Here are the key news stories impacting Neogen this week:

Positive Sentiment: Momentum remains strong: Neogen Corporation reached a new one-year high as its shares continued trading well above both the 50-day and 200-day moving averages. Elevated volume suggests increased investor interest and may be helping drive the stock higher. Neogen Sets New 1-Year High
Positive Sentiment: The company’s latest reported quarter exceeded expectations, with earnings of $0.09 per share versus the $0.06 consensus and revenue of $225.3 million versus estimates of $212.35 million. This earnings and revenue beat provides a fundamental backdrop for the recent rally.
Neutral Sentiment: Reports about a ₹600 crore, 6.5-times oversubscribed QIP concern Neogen Chemicals, not Neogen Corporation (NASDAQ: NEOG). Those articles should not be interpreted as a capital raise or catalyst for NEOG. Neogen Chemicals Raises Funds via QIP
Negative Sentiment: Investors remain mindful that Neogen Corporation’s revenue was essentially flat year over year in its latest reported quarter, while the company posted a slightly negative net margin. Analysts have also flagged valuation and debt risks, which could limit further gains if operating growth does not accelerate. Neogen Corporation Stock Holds as Revenue Falls Analysts Flag Valuation and Debt Risks

About Neogen

(Get Free Report)

Neogen Corporation develops and markets products and services designed to protect food, animals and people. The company’s offerings help customers detect, prevent and manage biological, chemical and physical hazards across the food production, agricultural and animal care industries.

Its food safety portfolio includes test kits and related technologies for detecting pathogens, allergens, mycotoxins, spoilage organisms, veterinary drug residues and other contaminants. Neogen also provides sanitation and hygiene products, diagnostic tools, laboratory services, software and training for food manufacturers, processors, retailers and other organizations involved in the food supply chain.

Neogen’s animal safety business serves livestock, poultry, companion animal and veterinary markets.